NONOF
NOVO NORDISK A/S B NEW by Novo-Nordisk A/S (NONOF)
$
78About NOVO NORDISK A/S B NEW by Novo-Nordisk A/S (NONOF)
Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.
Details
Daily high
$61.50
Daily low
$57.35
Price at open
$59.70
52 Week High
$149.55
52 Week Low
$57.35
Market cap
256.5B
Dividend yield
2.87%
Volume
12,146
Avg. volume
92,583
P/E ratio
17.57
NOVO NORDISK A/S B NEW by Novo-Nordisk A/S News
Details
Daily high
$61.50
Daily low
$57.35
Price at open
$59.70
52 Week High
$149.55
52 Week Low
$57.35
Market cap
256.5B
Dividend yield
2.87%
Volume
12,146
Avg. volume
92,583
P/E ratio
17.57